Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Pimm

Showing results (91-100 of 152) with videos related to

Pageof 16
Sort By:
Nuclear Medicine Communications|April 1, 1988
The implications of patient antibody response for the clinical usefulness of immunoscintigraphyA C Perkins, M V Pimm, M C Powell
Journal of Drug Targeting|January 1, 1993
Targeting of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate to the hepatocyte galactose-receptor in mice: visualisation and quantification by gamma scintigraphy as a basis for clinical targeting studiesM V Pimm, A C Perkins, R Duncan, et al.
International Journal of Cancer|December 15, 1979
Immunotherapy of an ascitic rat hepatoma with cord factor (trehalose-6, 6'-dimycolate) and synthetic analoguesM V Pimm, R W Baldwin, J Polonsky, et al.
European Journal of Nuclear Medicine|January 1, 1991
Anomalies in reduction-mediated technetium-99m labelling of monoclonal antibodiesM V Pimm, R S Rajput, M Frier, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiographyS Demignot, M V Pimm, S R Thorpe, et al.
Annales De L'Institut Pasteur|April 1, 1972
Tumour specific and embryonic antigen expression of chemically induced rat tumoursR W Baldwin, D Glaves, M V Pimm, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
The influence of anti-(ricin toxin A chain) monoclonal antibodies on the pharmacokinetics of ricin toxin A chain and recombinant ricin A chain in miceM V Pimm, B Gunn, J M Lord, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Biodistribution and tumour localisation of a daunomycin-monoclonal antibody conjugate in nude mice with human tumour xenograftsM V Pimm, M A Paul, Y Ogumuyiwa, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|December 1, 1994
Scintigraphic determination of the biodistribution of an 111In-labelled poly(L-lysine) backbone branched polypeptide drug carrier in tumour-bearing miceM V Pimm, A C Perkins, S J Gribben, et al.
European Journal of Cancer|April 1, 1981
Evaluation of intratumoral immunostimulants in the treatment of a transplantable rat mammary carcinomaN Willmott, E B Austin, M V Pimm, et al.
Pageof 16

Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Nuclear Medicine Communications|April 1, 1988
The implications of patient antibody response for the clinical usefulness of immunoscintigraphyA C Perkins, M V Pimm, M C Powell
Journal of Drug Targeting|January 1, 1993
Targeting of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate to the hepatocyte galactose-receptor in mice: visualisation and quantification by gamma scintigraphy as a basis for clinical targeting studiesM V Pimm, A C Perkins, R Duncan, et al.
International Journal of Cancer|December 15, 1979
Immunotherapy of an ascitic rat hepatoma with cord factor (trehalose-6, 6'-dimycolate) and synthetic analoguesM V Pimm, R W Baldwin, J Polonsky, et al.
European Journal of Nuclear Medicine|January 1, 1991
Anomalies in reduction-mediated technetium-99m labelling of monoclonal antibodiesM V Pimm, R S Rajput, M Frier, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiographyS Demignot, M V Pimm, S R Thorpe, et al.
Annales De L'Institut Pasteur|April 1, 1972
Tumour specific and embryonic antigen expression of chemically induced rat tumoursR W Baldwin, D Glaves, M V Pimm, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
The influence of anti-(ricin toxin A chain) monoclonal antibodies on the pharmacokinetics of ricin toxin A chain and recombinant ricin A chain in miceM V Pimm, B Gunn, J M Lord, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Biodistribution and tumour localisation of a daunomycin-monoclonal antibody conjugate in nude mice with human tumour xenograftsM V Pimm, M A Paul, Y Ogumuyiwa, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|December 1, 1994
Scintigraphic determination of the biodistribution of an 111In-labelled poly(L-lysine) backbone branched polypeptide drug carrier in tumour-bearing miceM V Pimm, A C Perkins, S J Gribben, et al.
European Journal of Cancer|April 1, 1981
Evaluation of intratumoral immunostimulants in the treatment of a transplantable rat mammary carcinomaN Willmott, E B Austin, M V Pimm, et al.
Pageof 16